|
Volumn 38, Issue 1, 2015, Pages e7-e8
|
Effect of exogenous intravenous administrations of GLP-1 and/Or GIP on circulating pro-Atrial natriuretic peptide in subjects with different stages of glucose tolerance
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATRIAL NATRIURETIC FACTOR;
GASTRIC INHIBITORY POLYPEPTIDE;
GLUCAGON LIKE PEPTIDE 1;
HEMOGLOBIN A1C;
PLACEBO;
ADULT;
CLINICAL ARTICLE;
COHORT ANALYSIS;
CONTROLLED STUDY;
FEMALE;
GLUCOSE TOLERANCE;
HUMAN;
LETTER;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
PROTEIN BLOOD LEVEL;
PROTEIN PROTEIN INTERACTION;
STEADY STATE;
AGED;
BLOOD;
GLUCOSE INTOLERANCE;
INTRAVENOUS DRUG ADMINISTRATION;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
ADMINISTRATION, INTRAVENOUS;
AGED;
ATRIAL NATRIURETIC FACTOR;
DIABETES MELLITUS, TYPE 2;
FEMALE;
GASTRIC INHIBITORY POLYPEPTIDE;
GLUCAGON-LIKE PEPTIDE 1;
GLUCOSE INTOLERANCE;
HUMANS;
MALE;
MIDDLE AGED;
OVERWEIGHT;
|
EID: 84920025603
PISSN: 01495992
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc14-1452 Document Type: Letter |
Times cited : (10)
|
References (5)
|